# Nippon Sanso Matheson, Inc. – FDA Inspection, Apr 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/nippon-sanso-matheson-inc/6f6e686c-0c63-4a71-930c-0669315a5dde
Source feed: FDA_Inspections

> FDA inspection 1008335 of Nippon Sanso Matheson, Inc., April 05, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1008335
- Company Name: Nippon Sanso Matheson, Inc.
- Inspection Date: 2017-04-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/sean-r-marcsisin/45c910a9-9019-4419-9af8-b1c9f3b1e976)

Company: https://www.keypedia.com/companies/nippon-sanso-matheson-inc/363a94c6-981b-4e0d-b0ef-b21fdc10df3e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c